Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel-Reference-Cited by-同舟云学术

Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel

Published:2016-12 Issue:6 Volume:70 Page:1052-1068
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Seisen Thomas,Peyronnet Benoit,Dominguez-Escrig Jose Luis,Bruins Harman M.,Yuan Cathy Yuhong,Babjuk Marko,Böhle Andreas,Burger Maximilian,Compérat Eva M.,Cowan Nigel C.,Kaasinen Eero,Palou Joan,van Rhijn Bas W.G.,Sylvester Richard J.,Zigeuner Richard,Shariat Shahrokh F.,Rouprêt Morgan

Publisher

Elsevier BV

Subject

Urology

Reference41 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. European Association of Urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update;Rouprêt;Eur Urol,2015

3. Potential role of photodynamic techniques combined with new generation flexible ureterorenoscopes and molecular markers for the management of urothelial carcinoma of the upper urinary tract;Audenet;BJU Int,2012

4. Risk-adapted strategy for the kidney-sparing management of upper tract tumours;Seisen;Nat Rev Urol,2015

5. Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with T1a-T1b renal mass and normal preoperative renal function;Capitanio;Eur Urol,2015

Cited by 235 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of tumor size in ureteral cancer following segmental ureterectomy;Urologic Oncology: Seminars and Original Investigations;2024-11

2. Disitamab vedotin (RC48) long-term regimen in a post-nephroureterectomy patient with metastases: a case report;Frontiers in Oncology;2024-09-13

3. HER2 expression in upper tract urothelial carcinoma and the relationship with clinicopathological characteristics—an analysis of 155 patients in Southwest China;World Journal of Urology;2024-09-13

4. Organerhaltende Therapien beim Urothelkarzinom des oberen Harntrakts;Die Urologie;2024-09-13

5. Das metastasierte und fortgeschrittene Urothelkarzinom des oberen Harntraktes – eigene Entität oder doch kleine Schwester des Blasenkarzinoms?;Die Urologie;2024-09-02